Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
Title
Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.
Creator
Gonakoti Sripriya; Khullar Sanjiv; Rajkumar Aarthi
Publisher
The American journal of case reports
Date
2019
2019-01
Description
BACKGROUND Olmesartan, an angiotensin receptor blockade class of antihypertensive medication has recently been associated with a seronegative sprue like enteropathy. Patients typically present with diarrhea and weight loss often prompting exhaustive diagnostic workup. Discontinuation of the drug leads to dramatic recovery and hence, physicians need to be aware of olmesartan associated enteropathy (OAE) in order to avoid unnecessary testing. CASE REPORT A
Subject
Humans; Male; Middle Aged; Colitis; *Weight Loss; Antihypertensive Agents/*adverse effects; Diarrhea/*chemically induced; Imidazoles/*adverse effects; Tetrazoles/*adverse effects; Vomiting/*chemically induced; Lymphocytic/*chemically induced
Identifier
URL Address
Rights
Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).
Pages
111-116
Volume
20
Citation
Gonakoti Sripriya; Khullar Sanjiv; Rajkumar Aarthi, “Olmesartan Associated Enteropathy: A Rare Underdiagnosed Cause of Diarrhea and Weight Loss.,” NEOMED Bibliography Database, accessed May 10, 2024, https://neomed.omeka.net/items/show/6319.